Factors influencing the clinical outcome of methicillin-resistant Staphylococcus aureus bacteraemia

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 3, 2012, Pages 295-301

  Albur, M S ^a   Bowker, K ^a   Weir, I ^b   MacGowan, A ^a  

^a NORTH BRISTOL NHS TRUST   (United Kingdom)

^b UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METICILLIN; VANCOMYCIN;

ADULT; AGE; AGED; ARTICLE; BACTERIAL GENE; CLINICAL ARTICLE; DEATH; DRUG BLOOD LEVEL; EXPLORATORY RESEARCH; FACTORIAL ANALYSIS; FEMALE; HOST; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TEACHING HOSPITAL; TREATMENT OUTCOME; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 84857039895     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1310-2     Document Type: Article

References (27)

1. NA van der Mee-Marquet AS Domelier N Girard R Quentin 2004 Epidemiology and typing of S. aureus strains isolated from bloodstream infections J Clin Microbiol 42 5650 5657 15583295 10.1128/JCM.42.12.5650-5657.2004 (Pubitemid 39664349)
2. DJ Diekema SE Beekmann KC Chapin KA Morel E Munson GV Doern 2003 Epidemiology and outcome of nosocomial and community-onset bloodstream infection J Clin Microbiol 41 3655 3660 12904371 10.1128/JCM.41.8.3655-3660.2003 1:STN:280:DC%2BD3szoslSgtQ%3D%3D (Pubitemid 36994698)
3. DH Wyllie DW Crook TE Peto 2006 Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study BMJ 333 281 284 16798756 10.1136/bmj.38834.421713.2F (Pubitemid 44406689)
4. VG Fowler Jr JM Miro B Hoen, et al. 2005 Staphylococcus aureus endocarditis: a consequence of medical progress JAMA 293 3012 3021 15972563 10.1001/jama.293.24.3012 1:CAS:528:DC%2BD2MXlsVenurs%3D (Pubitemid 40965071)
5. Health Protection Agency (2010) Quarterly results from the mandatory surveillance of MRSA bacteraemia, June 2010 report. www.hpa.org.uk. Accessed 4 June 2011
6. SE Cosgrove G Sakoulas EN Perenceivich MJ Scwwaber AW Karchmer Y Carmeli 2003 Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteraemia: a meta-analysis Clin Infect Dis 36 53 59 12491202 10.1086/345476 (Pubitemid 36099097)
7. M Whitby M-L McLaws G Berry 2001 Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis Med J Aust 175 264 267 11587259 1:STN:280:DC%2BD3MrktVygtg%3D%3D (Pubitemid 32851061)
8. WR McCabe GG Jackson 1962 Gram-negative bacteremia, I: etiology and ecology Arch Intern Med 110 847 855 10.1001/archinte.1962.03620240029006
9. Clinical Standards and Laboratory Standards Institute (2006) Methods for dilution susceptibility tests for bacteria that grow aerobically: approved standard, 7th edn. CLSI, Wayne, pp M7-A7
10. KE Bowker HA Holt DS Reeves AP MacGowan 1996 Bactericidal activity, post-antibiotic effect and modified controlled effective regrowth time of meropenem at high concentrations J Antimicrob Chemother 38 1055 1060 9023653 10.1093/jac/38.6.1055 1:CAS:528:DyaK2sXhtFGitrg%3D (Pubitemid 27073285)
11. M Wootton RA Howe R Hillman TR Walsh PM Bennett AP McGowan, et al. 2001 A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital JAC 47 399 403 11266410 1:CAS:528:DC%2BD3MXjtVamtLk%3D (Pubitemid 32303403)
12. S Monecke R Ehricht 2005 Rapid genotyping of methicillin-resistant Staphylococcus aureus isolates using miniaturised oligonucleotide arrays Clin Microbiol Infect 11 825 833 16153257 10.1111/j.1469-0691.2005.01243.x 1:CAS:528:DC%2BD2MXhtFeqtrfL (Pubitemid 41341716)
13. S Monecke P Slickers H Hotzel, et al. 2006 Microarray-based characterisation of a Panton-Valentine leukocidin-positive community-acquired strain of methicillin-resistant Staphylococcus aureus Clin Microbiol Infect 12 718 728 16842566 1:CAS:528:DC%2BD28XosFamu70%3D (Pubitemid 43983796)
14. KB Laupland DL Church M Mucenski LR Sutherland H Dele Davies 2003 Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections J Infect Dis 187 1452 1459 12717627 10.1086/374621 (Pubitemid 36549691)
15. RG Corey AW Karchmer AS Bayer LG Miller 2008 Methicillin-resistant Staphylococcus aureus: an evolving clinical challenge Clin Infect Dis 46 Suppl 5 339 394
16. G Sakoulas PA Moise-Broder J Schentag A Forrest RC Moellering Jr M Eliopoulos 2004 Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of MRSA bacteraemia J Clin Microbiol 42 6 2398 2402 15184410 10.1128/JCM.42.6.2398-2402.2004 1:CAS:528:DC%2BD2cXlslamtLY%3D (Pubitemid 38747480)
17. PA Moise DS Smyth N El-Fawal DA Robinson PN Holden A Forrest G Sakoulas 2008 Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia JAC 61 85 90 18042628 1:CAS:528:DC%2BD1cXhtFWgtw%3D%3D
18. A Soriano F Marco JA Martinez E Pisos M Almela VP Dimova D Alamo M Ortega J Lopez J Mensa 2008 Influence of vancomycin MIC on the treatment of methicillin-resistant Staphylococcus aureus bacteraemia Clin Infect Dis 46 193 200 18171250 10.1086/524667 1:CAS:528:DC%2BD1cXhvVClsbk%3D (Pubitemid 351269157)
19. M Rybak B Lomaestro J Rotschafer R Moellering W Criag M Billeter, et al. 2009 Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and Society of Infectious Diseases Pharmacists Clin Infect Dis 49 325 327 19569969 10.1086/600877
20. VG Fowler CL Nelson LM McIntyre BN Kreiswirth A Monk, et al. 2007 Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infection J Infect Dis 196 738 747 17674317 10.1086/520088 (Pubitemid 47293857)
21. S Jarraud C Mougel J Thioulouse G Lina H Meugnier F Forey X Nesme J Etienne F Vandenesch 2002 Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease Infect Immun 70 2 631 641 11796592 10.1128/IAI.70.2.631-641.2002 1:CAS:528: DC%2BD38XoslOrtQ%3D%3D (Pubitemid 34083822)
22. RJ Williams JM Ward B Henderson S Poole BP O'Hara M Wilson SP Nair 2000 Identification of a novel gene cluster encoding staphylococcal exotoxin-like proteins: Characterization of the prototypic gene and its protein product, set1 Infect Immun 68 4407 4415 10899837 10.1128/IAI.68.8.4407-4415.2000 1:CAS:528:DC%2BD3cXltF2qtLg%3D (Pubitemid 30497705)
23. AM Al-Shangiti CE Naylor SP Nair DC Briggs B Henderson BM Chain 2004 Structural relationships and cellular tropism of staphylococcal superantigen-like proteins Infect Immun 72 4261 4270 15213171 10.1128/IAI.72.7.4261-4270.2004 1:CAS:528:DC%2BD2cXlslWitr8%3D (Pubitemid 38821941)
24. SH Rooijakkers JA van Strijp 2007 Bacterial complement evasion Mol Immunol 44 23 32 16875737 10.1016/j.molimm.2006.06.011 1:CAS:528: DC%2BD28XhtFartLjJ (Pubitemid 44647108)
25. Taylor A, Basu I, Langley R, Angel C, Dunbar R, Fraser J (2006) Staphylococcal superantigen-like protein 13 targets human endothelial cells. O.39 & P.108. ISSSI, Maastricht
26. MM Dinges PM Orwin PM Schlievert 2000 Exotoxins of Staphylococcus aureus Clin Microbiol Rev 13 16 34 10627489 10.1128/CMR.13.1.16-34.2000 1:CAS:528:DC%2BD3cXntFagtw%3D%3D (Pubitemid 30039341)
27. H Ammerlaan H Seifert S Harbarth C Brun-Buisson A Torres M Antonelli, et al. 2009 Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 western European countries (SEPIA study group) Clin Infect Dis 49 997 1005 19719417 10.1086/605555 1:CAS:528:DC%2BD1MXhtlehs73E